Deep Genomics

Revolutions in AI, RNA biology and automation

Toronto, Canada · Founded 2015 · $236.7M raised

Headquarters
Toronto
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$236.7M
Last Round
$180.0M Series CJul 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Deep Genomics is a Toronto-based biotechnology company at the forefront of AI-powered drug discovery. Founded in 2015 by Brendan Frey, a professor at the University of Toronto and co-founder of the Vector Institute for Artificial Intelligence, the company has built proprietary AI platforms that untangle the complexity of RNA biology to identify novel therapeutic targets and evaluate thousands of drug candidates. Deep Genomics' technology suite includes BigRNA, the world's first AI foundation model for RNA biology, and its successor BigRNA+, which expands target identification into complex genetic diseases. The interdisciplinary team of 100+ experts spans artificial intelligence, molecular biology, machine learning, organic chemistry, and clinical development. The company has deep scientific advisory relationships with Yann LeCun and other leading researchers.

Summary

Deep Genomics is an Artificial Intelligence company based in Toronto, Canada, founded in 2015. It has raised $236.7M in total across 4 rounds, most recently a $180.0M Series C round in Jul 2021. Investors include Khosla Ventures, SoftBank and Future Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJul 2021
$180.0M

Sign up to see all 4 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series FTotal funding$3.8BJan 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Deep Genomics on Indexed.vc
<a href="https://indexed.vc/companies/deep-genomics"><img src="https://indexed.vc/api/badge/company/deep-genomics" alt="Deep Genomics on Indexed.vc" width="260" height="76" /></a>